Posts by growthzone
Sen. Tillis joins NCBIO members for Q&A
Sen. Thom Tillis addressed manufacturing capacity, China, intellectual property protections, workforce development and more with NCBIO members during a legislative forum held online Friday, Jan. 14. He emphasized that he and his staff were eager to hear the concerns, issues and ideas of North Carolina’s life sciences industry.
Read MoreWho pays to create new medicines?
Does government spending on drug development justify government price controls on medicines? Not when the private sector spends $102 billion on clinical R&D and the NIH spends less than $3 billion.
Read MoreNCBIO forum explores ways to improve recruitment and experience for patients in clinical trials
Patients and research organizations came together at the NCBIO Clinical Trials Forum to talk about ways to make recruiting and retaining patients easier for clinical trials. The forum was held Wednesday, Dec. 8 at the NC Biotechnology Center.
Read MoreLaura Gunter named to Council of State Bioscience Associations board
Laura Gunter named to Council of State Bioscience Associations board Laura Gunter, NCBIO president NCBIO President Laura Gunter has been elected to the Board of Directors of the Council of State Bioscience Associations. Gunter will serve a two-year term beginning 2022.  “We are thrilled to announce our new slate of incredibly accomplished and esteemed…
Read MoreLaura Gunter: Biotech policies should protect patients, innovation
Laura Gunter: Biotech policies should protect patients, innovation The ongoing response to the COVID-19 pandemic has highlighted the critical role of the North Carolina life sciences industry in battling our most serious public health threats. When faced with the threat of COVID-19, biotechnology companies — many based right here in North Carolina — answered the…
Read MoreNatacha Janvier joins NCBIO as membership director
Natacha Janvier joins NCBIO as membership director Natacha Janvier has joined NCBIO as the organization’s new membership director. Janvier began her new role on Nov. 15. “We are very excited to have Natacha joining us,” said NCBIO President Laura Gunter. “She has an impressive background in North Carolina’s life sciences industry, and she will be…
Read MorePharmaceutical Prescribing Labels: An Enormous Opportunity to Eliminate Pointless Paper Waste in the United States
Pharmaceutical Prescribing Labels: An Enormous Opportunity to Eliminate Pointless Paper Waste in the United States This post originally appeared on the website of the Environmental Paper Network. A serious approach to addressing climate change must include the proactive elimination of unnecessary paper consumption. Paper is an important and useful material that should be produced and…
Read MoreBIO: Build Back Better Act weakens U.S. innovation ecosystem, hurts patients
BIO: Build Back Better Act weakens U.S. innovation ecosystem, hurts patients Michelle McMurry-Heath, M.D., Ph.D., president and CEO of the Biotechnology Innovation Organization, released the following statement after the House of Representatives passed the Build Back Better Act on Nov. 19: “The legislation that passed the House today will upend a successful Medicare system and…
Read MoreNC colleges and universities review workforce training programs with BMF members
NC colleges and universities review workforce training programs with BMF members Representatives from the NC Community Colleges’ BioNetwork, the NC Pharmaceutical Services Network, BRITE at NC Central University, NC A&T University and North Carolina State University’s BTEC were all on hand Tuesday, Nov. 16, at the NCBIO Biotech Manufacturers Forum Meeting to discuss their efforts…
Read MoreGene therapy pioneer Jude Samulski delivers powerful keynote at NCBIO 2021 Annual Meeting
Gene therapy pioneer Jude Samulski delivers powerful keynote at NCBIO 2021 Annual Meeting Jude Samulski, Ph.D., told NCBIO Annual Meeting attendees that the field of gene therapy is the beginning of something that will transform lives forever. Therapies created today for rare diseases will tomorrow generate treatments for common ills like high cholesterol, diabetes and…
Read More